300016.SZ · 北陆药业
China A-shares · RS rating 72 · As of 2026-10-14
| Price | 8.34 CNY |
|---|---|
| 1-day change | -3.8% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 69 / 63 / 61 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 26 / 33 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +10.2% |
| Distance from 52-week high | +25.5% |
| Market cap (USD) | $796.8M |